MedTrace Logo

AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding

NCT04804345 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 693

Last updated 2022-03-03

No results posted yet for this study

Summary

In this before-after multicenter study the authors tested the hypothesis that the prophylactic use of aprotinin compared to tranexamic acid could reduce the proportion of patients presenting severe perioperative bleeding.

Conditions

  • Cardiac Surgery
  • Cardiopulmonary Bypass
  • High Risk Bleeding

Interventions

OTHER

standard of care

retrospective study: standard of care

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Alexandre OUATTARA, MD, PhD · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2021-08-31
Completion
2021-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04804345 on ClinicalTrials.gov